- home
- about us
- Investment Approach
- Client Service Approach
- Market Analysis Summary
- Mission Statement
- Value Proposition
- Team Biographies
- Firm ADV PDFs
- Form CRS
- Firm Brochure-Part 2A of Form ADV
- Brochure Supplement Amit Stavinsky
- Brochure Supplement Frank Parks
- Brochure Supplement Dominick Savo
- Brochure Supplement Richard Mason
- Brochure Supplement Joe Estes
- Brochure Supplement Jonathan Ezra
- Statement Of Financial Strength
- Job Opportunities
- Letter to Clients
- member log-in
- contact us
Latest News about BHVN
Recent news which mentions BHVN
New Psychedelics ETF Launches On NYSE Arca
February 02, 2022
From Benzinga
Is This a Smart Deal for Pfizer?
January 29, 2022
From Motley Fool
The Daily Biotech Pulse: Lilly Strikes Neurological R&D Collaboration, Valneva Confirms Vaccine Timelines, Biohaven Gains On Strong Migraine Drug Sales
January 06, 2022
From Benzinga
Biohaven's Zavegepant Pain Spray Aces Late-Stage Migraine Trial
December 06, 2021
Tickers
BHVN
From Benzinga
What 6 Analyst Ratings Have To Say About Biohaven Pharma Hldgs
November 10, 2021
Tickers
BHVN
From Benzinga
75 Biggest Movers From Yesterday
November 10, 2021
From Benzinga
58 Stocks Moving In Monday's Mid-Day Session
November 09, 2021
From Benzinga
From Benzinga
Jim Cramer: MGM Resorts Has Good Top Management
November 09, 2021
From Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
November 09, 2021
From Benzinga
The Daily Biotech Pulse: Double Dose Of Positive Tidings For Merck, Alkermes Slips On Partial Termination Of J&J Licensing Deal, Amgen Migraine Drug Data
November 09, 2021
From Benzinga
The Week Ahead In Biotech (Nov. 7-Nov. 13): Earnings Taper Off, Multiple Conference Presentations, IPOs And More
November 08, 2021
From Benzinga
Cramer Likes American Eagle Outfitters And These 2 Pharma Stocks
October 18, 2021
From Benzinga
10 Biggest Price Target Changes For Wednesday
October 06, 2021
From Benzinga
The Daily Biotech Pulse: Takeda Suspends Studies On Safety Scare, Acer's Sleep Disorder Drug Filing Accepted For Review, Voyager's Licensing Options Deal
October 06, 2021
From Benzinga
What 7 Analyst Ratings Have To Say About Biohaven Pharma Hldgs
October 05, 2021
Tickers
BHVN
From Benzinga
The Daily Biotech Pulse: Merck Rallies On Antiviral Pill Data, Gilead Files For Yescarta Label Expansion, Exscientia IPO
October 01, 2021
From Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
September 27, 2021
From Benzinga
Cramer Gives His Opinion On Service Corporation, Vertex And More
September 10, 2021
From Benzinga
The Daily Biotech Pulse: Cellect Jumps On First Apograft Transplantation, AstraZeneca, European Commission Bury Legal Hatchet, Cassava Defends Itself
September 03, 2021
From Benzinga
The Daily Biotech Pulse: Assembly Bio Halts HBV Study, Moderna Initiates Submission For COVID-19 Booster Dose, FDA Nod For BeiGene, Tiziana Out-Licenses Foralumab
September 02, 2021
From Benzinga
The Daily Biotech Pulse: Merck Releases Twin Dose Of Positive Tidings, Astellas Voluntarily Pauses Gene Therapy Study, Ascendis Offering
September 01, 2021
From Benzinga
Cramer Gives His Opinion On Zillow, SoFi And More
August 12, 2021
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.